Stock listing
Corline Biomedical Ab
Selected listing: CLBIO · OMXSTO · SEK · SE
Corline Biomedical Ab (Stockholm:CLBIO), Health Technology. Latest release May 8, 2026: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln.
- Ticker
- Stockholm:CLBIO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Stockholm
- Currency
- SEK
About Corline Biomedical Ab
The company focuses on developing innovative biomedical solutions. Its activities are centered around advancing healthcare technologies and improving patient outcomes.
Latest news from Corline Biomedical Ab
Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln
May 8, 2026
Corline Biomedical Q4 (Review): Case intact, but sales ramp-up needed to restore market confidence
February 18, 2026
CLBIO: FDA approval, US launch, and a major 10-year deal drove a pivotal commercial breakthrough
February 17, 2026
Corline Flags Share Issue Raising About SEK 9.24 Mln
January 9, 2026
CLBIO: Breakthrough quarter with FDA approval, long-term deal, and capital raise set stage for growth
November 18, 2025
Research Corline Biomedical Ab
Corline Biomedical Ab company profile
View the public company page for Corline Biomedical Ab on 6ix.
Corline Biomedical Ab news
Read company news and market updates connected to Corline Biomedical Ab.
Corline Biomedical Ab investor events
Find investor webinars, events, and replay context for Corline Biomedical Ab.